Author:
Jornil Jakob,Linnet Kristian
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry (medical),Toxicology,Pathology and Forensic Medicine
Reference35 articles.
1. Grasmader K, Verwohlt PL, Rietschel M, Dragicevic A, Muller M, Hiemke C, Freymann N, Zobel A, Maier W, Rao ML (2004) Impact of polymorphisms of cytochrome-P450 iso-enzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting. Eur J Clin Pharmacol 60:329–336
2. Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C (2007) Infl uence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 116:496–526
3. Kirchheiner J, Seeringer A (2007) Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes. Biochim Biophys Acta 1770:489–494
4. Sjoeqvist F, Eliasson E (2007) The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants. Clin Pharmacol Ther 81:899–902
5. Mulder H, Herder A, Wilmink FW, Tamminga WJ, Belitser SV, Egberts ACG (2006) The impact of cytochrome P450-2D6 genotype on the use and interpretation of therapeutic drug monitoring in long-stay patients treated with antidepressant and antipsychotic drugs in daily psychiatric practice. Pharmacoepidemiol Drug Saf 15:107–114
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献